Index of reports
> Cases with Renal Impairment (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Tolbutamide where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Tolbutamide side effects in male
Reported by a physician from Japan on 2012-04-06
Patient: male
Reactions: Blood Bilirubin Increased, Hyperkalaemia, Nausea, Hypoglycaemia, Renal Impairment, Blood Uric Acid Increased, Drug Specific Antibody Present, Hypertension, Azotaemia, Hypertriglyceridaemia
Drug(s) suspected as cause:
Actemra
Indication: Castleman's Disease
Start date: 2008-10-31
End date: 2009-03-06
Actemra
Start date: 2010-01-14
End date: 2010-12-02
Actemra
Start date: 2011-01-07
End date: 2011-02-04
Tolbutamide
Administration route: Oral
Indication: Diabetes Mellitus
Actemra
Start date: 2009-03-19
End date: 2010-01-04
Other drugs received by patient: Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Pursennid; Espo; Prednisolone; Prednisolone; Prednisolone; Lansoprazole; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Allopurinol; Goodmin; Promacta; Benidipine Hydrochloride; Bisolvon; Marzulene-S; Prednisolone; Prednisolone; Prednisolone; Persantin; Lendormin; Losartan Potassium; Nespo; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Pranlukast; Rebamipide; Myonal; Olopatadine HCL; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Pursennid; Singulair; Theolong; Prednisolone; Prednisolone; Prednisolone; Alfarol; Omeprazole; Neomallermin-TR; Kayexalate; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Advair Diskus 100 / 50; Nespo
Possible Tolbutamide side effects in male
Reported by a physician from Japan on 2011-10-17
Patient: male
Reactions: Hyperkalaemia, Hypoglycaemia, Renal Impairment, Blood Uric Acid Increased, Hypertension, Azotaemia, Antibody Test Positive, Hypertriglyceridaemia
Drug(s) suspected as cause:
Actemra
Start date: 2010-01-14
End date: 2010-12-02
Actemra
Start date: 2011-01-07
End date: 2011-02-04
Actemra
Start date: 2009-03-19
End date: 2010-01-04
Tolbutamide
Administration route: Oral
Indication: Diabetes Mellitus
Actemra
Indication: Castleman's Disease
Start date: 2008-10-31
End date: 2009-03-06
Other drugs received by patient: Espo; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Allopurinol; Pursennid; Lendormin; Pranlukast; Theolong; Rebamipide; Prednisolone; Prednisolone; Prednisolone; Singulair; Promac; Myonal; Olopatadine HCL; Nespo; Prednisolone; Prednisolone; Prednisolone; Omeprazole; Neomallermin-TR; Nespo; Persantin; Alfarol; Goodmin; Prednisolone; Prednisolone; Prednisolone; Pursennid; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Lansoprazole; Losartan Potassium; Marzulene-S; Kayexalate; Adoair; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Benidipine Hydrochloride; Bisolvon
|